Millennium Management
PHAR

Millennium Management’s Pharming Group PHAR Stock Holding History

Millennium Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,385
Closed -$360K – 6220
2025
Q4 		$360K Buy
+20,385
New +$321K ﹤0.01% 5144

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management's PHAR Position: Q1 2026 in Review

Millennium Management sold out of Pharming Group (PHAR) in Q1 2026, closing a stake of 20,385 shares — an estimated $360K sold.

Millennium Management first reported a position in PHAR in Q4 2025 and held it in 1 quarter. The position peaked at $360K in Q4 2025. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • Millennium Management reported no remaining Pharming Group position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 20,385 Pharming Group shares in Q1 2026, an estimated $360K.
  • Millennium Management first reported a position in Pharming Group in Q4 2025 and held it in 1 quarter.
  • Millennium Management's Pharming Group position peaked at $360K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.